Green methods for the simultaneous analysis of pharmaceutical mixtures present in disparate concentration ranges: Application to antidiabetic mixtures

Abstract Diabetes-mellitus is one of the most common chronic diseases worldwide. Today, many single-pill combinations exist and are indicated especially for diabetic patients who are unable to achieve sufficient glycemic-control with one active component. However, some of these combinations are formulated in concentration ratios that present a real challenge for their analysis and quality-control assessment. For instant, linagliptin (L) and saxagliptin (S) are two oral dipeptidylpeptidase‐4 inhibitors that have recently been formulated with metformin (M) in a ratio of 1:400 with almost no simple analytical methods offered in literature for their analysis in such disparate concentration-ratio. In this study, a simple, fast and green capillary electrophoretic (CE) method was established for the simultaneous determination of L and S with M in pharmaceutical-dosage-forms. The developed method was linear in the range of 2–200 μg.mL−1 for L and S and 10–2000 μg.mL−1 for M with r > 0.9993 with low LOD and LOQ values that allowed the proposed method to be successfully applied for the sensitive determination of S, L and M in their binary-combinations of S-M and L-M in pharmaceutical-dosage-forms despite the large differences in M and L or S doses. Upon comparison with the few reported-methods, the proposed-method offers the advantages of high separation efficiency and low solvent consumption. In addition to using simple aqueous-buffer that adds to the greenness of the method and decrease the cost of operation. The Eco-scale penalty points approach and the Green Analytical Procedure Index were applied to assess the greenness of the developed method. Results revealed that the proposed method is a greener alternative to the reported ones This allows our proposed-method to be used for the routine high-through-put analysis required in quality-control laboratories as an efficient and simple eco- friendly analytical-tool.

[1]  E. El-Kimary,et al.  HPTLC Determination of Three Gliptins in Binary Mixtures with Metformin. , 2015, Journal of chromatographic science.

[2]  E. Allen,et al.  Saxagliptin given in combination with metformin as initial therapy improves glycaemic control in patients with type 2 diabetes compared with either monotherapy: a randomized controlled trial , 2009, Diabetes, obesity & metabolism.

[3]  H. I. Aljohar,et al.  Stability-indicating capillary electrophoresis method for the simultaneous determination of metformin hydrochloride, saxagliptin hydrochloride, and dapagliflozin in pharmaceutical tablets , 2019, Journal of Liquid Chromatography & Related Technologies.

[4]  Jacek Namieśnik,et al.  Analytical eco-scale for assessing the greenness of analytical procedures , 2012 .

[5]  A. Saad,et al.  Simultaneous spectrophotometric determination of compounds having relatively disparate absorbance and concentration ranges; application to antidiabetic formulation of linagliptin and metformin. , 2018, Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy.

[6]  G. Bray,et al.  The metabolic syndrome : Epidemiology, Clinical Treatment, and Underlying mechanisms , 2008 .

[7]  C. Kapnissi-Christodoulou,et al.  Method Development by Use of Capillary Electrophoresis and Applications in Pharmaceutical, Biological and Natural Samples , 2012 .

[8]  Won Chan Lee,et al.  A retrospective study of persistence, adherence, and health economic outcomes of fixed-dose combination vs loose-dose combination of oral anti-diabetes drugs , 2016, Journal of medical economics.

[9]  J. Holst,et al.  Dipeptidyl Peptidase‐4 Inhibitors Administered in Combination With Metformin Result in an Additive Increase in the Plasma Concentration of Active GLP‐1 , 2010, Clinical pharmacology and therapeutics.

[10]  B. Ayoub UPLC simultaneous determination of empagliflozin, linagliptin and metformin , 2015 .

[11]  J. Goldman-Levine Combination Therapy When Metformin Is Not an Option for Type 2 Diabetes , 2015, The Annals of pharmacotherapy.

[12]  J. Shubrook,et al.  Use of oral combination therapy for type 2 diabetes in primary care: Meeting individualized patient goals , 2015, Postgraduate medicine.

[13]  D. Matthews,et al.  Dipeptidyl peptidase-4 inhibitors for treatment of type 2 diabetes mellitus in the clinical setting: systematic review and meta-analysis , 2012, BMJ : British Medical Journal.

[14]  J. Shaw,et al.  IDF Diabetes Atlas: Global estimates for the prevalence of diabetes for 2015 and 2040. , 2011, Diabetes research and clinical practice.

[15]  G. K. Mohan,et al.  SIMULTANEOUS DETERMINATION OF METFORMIN, LINAGLIPTIN IN JENTADUETO AND METFORMIN, SAXAGLIPTIN IN KOMBIGLYZE BY LC-MS METHOD , 2018 .

[16]  G. Schernthaner Fixed‐dose combination therapies in the management of hyperglycaemia in Type 2 diabetes: an opportunity to improve adherence and patient care , 2010, Diabetic medicine : a journal of the British Diabetic Association.

[17]  J. Płotka-Wasylka,et al.  A new tool for the evaluation of the analytical procedure: Green Analytical Procedure Index. , 2018, Talanta.